|
EFR3A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.07449999999932E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.52679999999972E-05 |
| Normal-vs-Stage2 |
6.105900E-02 |
| Normal-vs-Stage3 |
3.285900E-02 |
| Normal-vs-Stage4 |
5.378100E-03 |
| Stage1-vs-Stage2 |
8.622000E-01 |
| Stage1-vs-Stage3 |
7.258200E-01 |
| Stage1-vs-Stage4 |
8.851000E-01 |
| Stage2-vs-Stage3 |
9.314200E-01 |
| Stage2-vs-Stage4 |
9.390800E-01 |
| Stage3-vs-Stage4 |
8.379800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.587700E-04 |
| Normal-vs-AfricanAmerican |
3.88319998378961E-09 |
| Normal-vs-Asian |
4.184000E-01 |
| Caucasian-vs-AfricanAmerican |
2.780200E-04 |
| Caucasian-vs-Asian |
1.699980E-01 |
| AfricanAmerican-vs-Asian |
1.079490E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.160820E-03 |
| Normal-vs-Female |
2.11079999999919E-05 |
| Male-vs-Female |
2.429400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.384300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.740600E-03 |
| Normal-vs-Age(61-80Yrs) |
6.377500E-04 |
| Normal-vs-Age(81-100Yrs) |
3.180000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.019600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.400800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.994800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.490600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.580000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.999400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.905700E-02 |
| Normal-vs-Grade 2 |
2.479500E-02 |
| Normal-vs-Grade 3 |
3.24549999997092E-06 |
| Normal-vs-Grade 4 |
5.899800E-03 |
| Grade 1-vs-Grade 2 |
4.013800E-01 |
| Grade 1-vs-Grade 3 |
8.160400E-01 |
| Grade 1-vs-Grade 4 |
9.517200E-01 |
| Grade 2-vs-Grade 3 |
6.218100E-02 |
| Grade 2-vs-Grade 4 |
3.715400E-01 |
| Grade 3-vs-Grade 4 |
6.534000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.117030E-03 |
| Normal-vs-ccB subtype |
7.436200E-02 |
| ccA subtype-vs-ccB subtype |
4.176600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.324200E-03 |
| Normal-vs-N1 |
9.043000E-01 |
| N0-vs-N1 |
3.593000E-01 |
|
|
